Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

Masaki Maeda, Issei Saeki, Isao Sakaida, Hiroshi Aikata, Yasuyuki Araki, Chikara Ogawa, Kazuya Kariyama, Kazuhiro Nouso, Mikiya Kitamoto, Haruhiko Kobashi, Shuichi Sato, Hiroshi Shibata, Kouji Joko, Shintaro Takaki, Hiroyuki Takabatake, Akemi Tsutsui, Koichi Takaguchi, Tetsu Tomonari, Shinichiro Nakamura, Takakazu NagaharaAtsushi Hiraoka, Tomomitsu Matono, Masahiko Koda, Mari Mandai, Tomohiko Mannami, Akeri Mitsuda, Takashi Moriya, Kazuhisa Yabushita, Joji Tani, Takahito Yagi, Takahiro Yamasaki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered a safe and minimally invasive procedure. We previously reported that the mortality and complication rates for RFA were 0.038% (5/13,283 patients) and 3.54% (579 complications/16,346 procedures), respectively, from 1999 to 2010 (previous period). In this study, we investigated the clinical criteria for RFA and the mortality and complication rates from 2011 to 2015 (recent period). Methods: Data were collected from 25 centers by using a questionnaire developed by the Chugoku-Shikoku Society for Local Ablation Therapy of HCC. The criteria for RFA, RFA modification, use of image-guidance modalities, mortality, and complications during the previous and recent periods were compared. Results: We evaluated 11,298 procedures for 9,411 patients, including those that involved new devices (bipolar RFA and internally adjustable electrode system). The criterion of hepatic function for RFA increased from a Child-Pugh score ≤8 during the previous period to ≤9 during the recent period. The criteria regarding the tumor location and other risk factors have been expanded recently because of the increased use of several modifications of the RFA procedure and image-guidance modalities. The mortality rate was 0.064% (6/9,411 patients), and the complication rate was 2.92% (330 complications/11,298 procedures). There was no difference in mortality rates between the 2 periods (p = 0.38), but the complication rates was significantly lower during the recent period (p = 0.038). Discussion and Conclusions: Our findings confirmed that RFA, including the use of new devices, is a low-risk procedure for HCC, despite the expansion of the criteria for RFA during the recent period.

Original languageEnglish
Pages (from-to)50-62
Number of pages13
JournalLiver Cancer
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 1 2020

Keywords

  • Complication
  • Hepatocellular carcinoma
  • Mortality
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Hepatology
  • Oncology

Fingerprint Dive into the research topics of 'Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients'. Together they form a unique fingerprint.

  • Cite this

    Maeda, M., Saeki, I., Sakaida, I., Aikata, H., Araki, Y., Ogawa, C., Kariyama, K., Nouso, K., Kitamoto, M., Kobashi, H., Sato, S., Shibata, H., Joko, K., Takaki, S., Takabatake, H., Tsutsui, A., Takaguchi, K., Tomonari, T., Nakamura, S., ... Yamasaki, T. (2020). Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients. Liver Cancer, 9(1), 50-62. https://doi.org/10.1159/000502744